(VIANEWS) – DANONE (BN.PA), CARMILA (CARM.PA), TEXAF (TEXF.BR) are the highest payout ratio stocks on this list.
We have gathered information about stocks with the highest payout ratio at the moment. The payout ratio in itself isn’t a promise of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. DANONE (BN.PA)
131.08% Payout Ratio
Danone S.A. operates in the food and beverage industry in Europe, North America, China, North Asia, the Oceania, Latin America, the Asia Pacific, Africa, the Middle East, and the Commonwealth of Independent States. The company operates through three segments: Essential Dairy & Plant-Based, Specialized Nutrition, and Waters. It produces and distributes yogurts; milk products; coffee creamers, beverages, and drinks; plant-based products; and ice creams, frozen desserts, and cheese products under the Actimel, Activia, Alpro, Aptamil, Danette, Danio, Danonino, evian, Nutricia, Nutrilon, Volvic, Danone, Prostokvashino, Light & Free, Oikos, Danissimo, YoPRO, International Delight, SToK, Silk, and So Delicious, as well as under the licensed brand Dunkin' Donuts. The company also provides specialized nutrition products for pregnant and breastfeeding mothers, infants, and young children under the Aptamil, Nutrilon, Gallia, Cow & Gate, Bebelac, Blédina, Olvarit, and Happy Family Organics brands. In addition, it offers tube feeding products under the Nutrison name; oral nutritional supplements under the Fortimel and NutriDrink names; and hypoallergenic products for children with allergies primarily under the Aptamil ProSyneo, Aptamil Pepti Syneo, and Neocate Syneo names. Further, the company provides water with natural fruit extracts, fruit juice, and vitamins under the evian, Volvic, Aqua, Mizone, Bonafont, Salus, Hayat, Sirma, Fontvella, Lanjarón, Zywiec Zdroj, Villavicencio, and Villa del Sur brands. It distributes its products through retail chains and traditional market outlets; convenience stores; hospitals, clinics, and pharmacies; and e-commerce. The company was formerly known as Groupe Danone and changed its name to Danone S.A. in April 2009. Danone S.A. was incorporated in 1899 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, DANONE has a trailing twelve months EPS of €1.46.
PE Ratio
DANONE has a trailing twelve months price to earnings ratio of 40.9. Meaning, the purchaser of the share is investing €40.9 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.78%.
Volume
Today’s last reported volume for DANONE is 446527 which is 70.86% below its average volume of 1532590.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on May 9, 2023, the estimated forward annual dividend rate is 2 and the estimated forward annual dividend yield is 3.34%.
More news about DANONE.
2. CARMILA (CARM.PA)
65.79% Payout Ratio
The third listed company of shopping centres in Continental Europe, Carmila was created by Carrefour and major institutional investors to transform and enhance the shopping centres adjoining Carrefour stores in France, Spain and Italy. As of 30 June 2020, its portfolio consisted of 215 shopping centres, leaders in their catchment area, valued at 6.2 billion euros. Putting proximity at the heart of all its actions, Carmila aims to simplify life and improve the daily lives of merchants and customers in the heart of all territories. Driven by a true commercial culture, its teams integrate all the expertise dedicated to the attractiveness of its assets: operations, center management, marketing, local digital marketing, new business and CSR. Carmila is listed in Compartment A on Euronext-Paris under the symbol CARM. It benefits from the regime of listed real estate investment companies ("SIIC"). On September 18, 2017, Carmila joined the FTSE EPRA/NAREIT Global Real Estate (EMEA Region) indices. On September 24, 2018, Carmila joined the Euronext CAC Small, CAC Mid Small and CAC All-tradable indices.
Earnings Per Share
As for profitability, CARMILA has a trailing twelve months EPS of €1.56.
PE Ratio
CARMILA has a trailing twelve months price to earnings ratio of 9.82. Meaning, the purchaser of the share is investing €9.82 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.98%.
More news about CARMILA.
3. TEXAF (TEXF.BR)
62.66% Payout Ratio
Texaf S.A. develops, owns, and leases real estate properties in Kinshasa. It operates through Real Estate, Digital, and Quarries segments. The company's portfolio comprises 333 homes, including 53 villas and 280 apartments with a residential area of 62,192 square meters; 26,313 square meters of office and retail space; and 30,146 square meters of warehouses, as well as TEXAF digital campus. It also supplies sandstones for use in concrete production, asphalt for roads, and civil engineering projects. The company was founded in 1925 and is headquartered in Brussels, Belgium. Texaf S.A. is a subsidiary of Société Financière Africaine.
Earnings Per Share
As for profitability, TEXAF has a trailing twelve months EPS of €2.27.
PE Ratio
TEXAF has a trailing twelve months price to earnings ratio of 15.33. Meaning, the purchaser of the share is investing €15.33 for every euro of annual earnings.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on May 24, 2023, the estimated forward annual dividend rate is 1.43 and the estimated forward annual dividend yield is 3.97%.
Moving Average
TEXAF’s value is below its 50-day moving average of €35.11 and higher than its 200-day moving average of €33.95.
Yearly Top and Bottom Value
TEXAF’s stock is valued at €34.80 at 02:10 EST, way below its 52-week high of €3,640.00 and way above its 52-week low of €31.60.
More news about TEXAF.
4. SANOFI (SAN.PA)
50% Payout Ratio
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Earnings Per Share
As for profitability, SANOFI has a trailing twelve months EPS of €6.49.
PE Ratio
SANOFI has a trailing twelve months price to earnings ratio of 15.48. Meaning, the purchaser of the share is investing €15.48 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.77%.
Yearly Top and Bottom Value
SANOFI’s stock is valued at €100.46 at 02:10 EST, under its 52-week high of €104.38 and way above its 52-week low of €76.45.
Moving Average
SANOFI’s worth is higher than its 50-day moving average of €93.85 and way higher than its 200-day moving average of €88.69.
Sales Growth
SANOFI’s sales growth is 9.4% for the present quarter and 2.5% for the next.
Growth Estimates Quarters
The company’s growth estimates for the current quarter is 3.6% and a drop 1.7% for the next.
More news about SANOFI.
